Biomarkers in Diagnostics & Therapeutics 2011

By: Event Protocol  16/12/2010
Keywords: Healthcare, Networking, Conferences


The global biomarker market is estimated to be $20.5 billion by 2014. This figure could be underestimated, looking at the potential of biomarkers to improve drug success while facilitating co-development with clinical diagnostics for disease prediction. BDT2011 will discuss values of biomarker applications and examine their potential to drive developments in genomics medicine and personalized healthcare.


·         Biomarkers propelling developments in molecular diagnostics

·         Biomarkers streamlining the process of drug discovery & development

·         Biomarkers in the co-development of drugs & diagnostics

·         Predictive biomarkers: Enabling preemptive actions in disease development

·         Advancing biomarker discovery & validation

·         Gearing up for the marathon of personalized medicine

Visit for full agenda

Keywords: Biotechnology, Conferences, Healthcare, Life Sciences, Meetings, Networking, Pharmaceutical, Professional, Seminars